Status and phase
Conditions
Treatments
About
In this research study we want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
46 participants in 2 patient groups
Loading...
Central trial contact
Aparna Patnaik, BA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal